Compositions and methods of treatment with glutathione
AU2021276517B2Pending Publication Date: 2026-10-01AURO PHARMACEUTICALS INC
2 Cites 0 Cited by
Patent Information
- Application Number
- AU2021276517
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-05-22
- Filing Date
- 2021-05-20
- Publication Date
- 2026-10-01
- Estimated Expiration
- 2041-05-20
Abstract
A topical composition comprising a nanonised L-glutathione and cyclodextrin complex, together with ascorbic acid in a weight ratio of glutathione to ascorbic acid from 7:1 to 15:1 and from 1:1 to 1:15 and a further compound comprising dexpanthenol, thiamine, benzalkonium chloride, sodium hyaluronate or acetyl-L-cysteine, which composition is topically administered for treating the symptoms of viral infection including COVID-19 and influenza, and for treating herpes simplex, herpes zoster, post herpetic neuralgia, genital herpes, alcohol detoxification, high triglycerides, age or liver spots and lupus.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Reduced glutathione percutaneous absorption preparation and preparation method thereof
CN102100904A
Method for stabilization and delivery of therapeutic molecules
US20170095561A1